Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

ABSTRACT: VM202 is a plasmid DNA encoding two isoforms of hepatocyte growth factor (HGF). A previous phase II study in subjects with painful diabetic peripheral neuropathy (DPN) showed significant reductions in pain. A phase III study was conducted to evaluate the safety and efficacy of VM202 in DPN...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, John A., Shaibani, Aziz, Sang, Christine N., Christiansen, Mark, Kudrow, David, Vinik, Aaron, Shin, Nari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212761/
https://www.ncbi.nlm.nih.gov/pubmed/33465273
http://dx.doi.org/10.1111/cts.12977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212761/
https://www.ncbi.nlm.nih.gov/pubmed/33465273
http://dx.doi.org/10.1111/cts.12977

Ejemplares similares